Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

Key Points The systematic review suggests that first-line antenatal management in FNAIT is weekly IVIG administration. Noninvasive management is effective without the relatively high rate of adverse outcomes seen in invasive strategies.

authors

Winkelhorst, Dian
Murphy, Michael F
Greinacher, Andreas
Shehata, Nadine
Bakchoul, Taman
Massey, Edwin
Baker, Jillian
Lieberman, Lani
Tanael, Susano
Hume, Heather
Arnold, Donald
Baidya, Shoma
Bertrand, Gerald
Bussel, James
Kjaer, Mette
Kaplan, Cécile
Kjeldsen-Kragh, Jens
Oepkes, Dick
Ryan, Greg

status

published

publication date

March 16, 2017

has subject area

1102 Cardiorespiratory Medicine and Haematology (FoR)
1103 Clinical Sciences (FoR)
1114 Paediatrics and Reproductive Medicine (FoR)
Adult (MeSH)
Disease Management (MeSH)
Female (MeSH)
Fetal Diseases (MeSH)
Humans (MeSH)
Immunoglobulins, Intravenous (MeSH)
Immunology (Science Metrix)
Infant, Newborn (MeSH)
Intracranial Hemorrhages (MeSH)
Mothers (MeSH)
Pregnancy (MeSH)
Prenatal Care (MeSH)
Steroids (MeSH)
Thrombocytopenia, Neonatal Alloimmune (MeSH)
Treatment Outcome (MeSH)
Young Adult (MeSH)

published in

Blood Journal